Biomarkers of Microbiome Disruption for Patient Stratification in Clinical Trials of Microbiome Therapeutics in IBD
Time: 4:30 pm
day: Conference Day One
Details:
- Microbiome heterogeneity in structural, functional, and immuno-modulatory properties in IBD
- Baseline biomarkers predictive of microbiome therapeutic pharmacodynamics in IBD
- Relating microbiome disruption and immuno-modulatory properties to inform patient stratification
